BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 33392895)

  • 21. [Vogt-Koyanagi-Harada syndrome in the setting of vemurafenib therapy for metastatic melanoma: a case report].
    Ren XT; Guo T; Yang F; Wu WY; Dou HL; Li XM
    Zhonghua Yan Ke Za Zhi; 2022 Nov; 58(11):925-928. PubMed ID: 36348532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of Vogt-Koyanagi-Harada disease-like uveitis during treatment by anti-programmed death-1 antibody: a case report.
    Wang JN; Zhang Y; Huang CY; Li K; Yu XB
    BMC Ophthalmol; 2024 Jun; 24(1):240. PubMed ID: 38849786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravitreal triamcinolone acetonide in Vogt-Koyanagi-Harada syndrome.
    Karacorlu M; Arf Karacorlu S; Ozdemir H
    Eur J Ophthalmol; 2006; 16(3):481-3. PubMed ID: 16761256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The contribution of indocyanine green angiography to the appraisal and management of Vogt-Koyanagi-Harada disease.
    Bouchenaki N; Herbort CP
    Ophthalmology; 2001 Jan; 108(1):54-64. PubMed ID: 11150265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Vogt-Koyanagi-Harada disease].
    Kjeka O; Krohn J
    Tidsskr Nor Laegeforen; 2005 Aug; 125(16):2195-7. PubMed ID: 16138134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vogt-Koyanagi-Harada syndrome. A case report.
    Iversen TH; Sverrisson T
    Acta Ophthalmol (Copenh); 1986 Apr; 64(2):235-8. PubMed ID: 3727967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retinal vessel oxygen saturation is affected in uveitis associated with Vogt-Koyanagi-Harada disease.
    Abu El-Asrar AM; AlBloushi AF; Gikandi PW; Hardarson SH; Stefánsson E
    Br J Ophthalmol; 2019 Dec; 103(12):1695-1699. PubMed ID: 30798260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Annular choroidal detachment in a patient with Vogt-Koyanagi-Harada disease.
    Yamamoto N; Naito K
    Graefes Arch Clin Exp Ophthalmol; 2004 Apr; 242(4):355-8. PubMed ID: 14963715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vogt-Koyanagi-Harada disease developed during chemotherapy for Hodgkin lymphoma: a case report.
    Koyama M; Nishijima E; Honda T; Gonmori-Ohta C; Sasamoto T; Tanaka K; Watanabe A; Nakano T; Akiyama M
    BMC Ophthalmol; 2024 Mar; 24(1):115. PubMed ID: 38481205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Indocyanine green angiography in Vogt-Koyanagi-Harada disease: angiographic signs and utility in patient follow-up.
    Herbort CP; Mantovani A; Bouchenaki N
    Int Ophthalmol; 2007; 27(2-3):173-82. PubMed ID: 17457515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Indocyanine green angiographic findings in Vogt-Koyanagi-Harada disease.
    Oshima Y; Harino S; Hara Y; Tano Y
    Am J Ophthalmol; 1996 Jul; 122(1):58-66. PubMed ID: 8659599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multimodal Imaging Approach in a Patient with Vogt-Koyanagi-Harada-like Syndrome Due to Dabrafenib and Trametinib Use for Cutaneous Melanoma.
    Bellanca RF; Pinna A; Catania G; Belcastro E; Angi M; D'Amico Ricci G
    Ocul Immunol Inflamm; 2023 Feb; 31(2):402-406. PubMed ID: 35113757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unilateral Ocular Manifestations of Vogt-Koyanagi-Harada Disease.
    Tsui E; Bottini A; Ghadiali Q; Balaratnasingam C; Barbazetto I
    Ocul Immunol Inflamm; 2018; 26(8):1297-1300. PubMed ID: 29020488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concomitant choroidal inflammation during anterior segment recurrence in Vogt-Koyanagi-Harada disease.
    Bacsal K; Wen DS; Chee SP
    Am J Ophthalmol; 2008 Mar; 145(3):480-486. PubMed ID: 18191100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vogt-Koyanagi-Harada syndrome (uveomeningoencephalitic syndrome).
    Manethova K; Ernest J; Hrevus M
    Eur J Ophthalmol; 2017 Jan; 27(1):e5-e8. PubMed ID: 28009404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of Vogt-Koyanagi-Harada Disease-like Uveitis during Treatment by Anti-programmed Death Ligand-1 Antibody for Non-small Cell Lung Cancer: A Case Report.
    Suwa S; Tomita R; Kataoka K; Ueno S
    Ocul Immunol Inflamm; 2022 Aug; 30(6):1522-1526. PubMed ID: 33797309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Full-field electroretinogram behavior in Vogt-Koyanagi-Harada disease: a 24-month longitudinal study in patients from acute onset evaluated with multimodal analysis.
    Sakata VM; Lavezzo MM; da Silva FT; Rodriguez EEC; Morita C; Abdallah SF; Oyamada MK; Hirata CE; Yamamoto JH
    Graefes Arch Clin Exp Ophthalmol; 2019 Oct; 257(10):2285-2295. PubMed ID: 31440820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PREDICTIVE ROLE OF SWEPT SOURCE OCT ANGIOGRAPHY IN RELAPSING VOGT-KOYANAGI-HARADA DISEASE.
    Interlandi E; Pellegrini F; Papayannis A; Latanza L; Pece A; Pavesio C
    Retin Cases Brief Rep; 2023 Jul; 17(4):414-418. PubMed ID: 35880955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vogt-Koyanagi-Harada disease.
    O'Keefe GA; Rao NA
    Surv Ophthalmol; 2017; 62(1):1-25. PubMed ID: 27241814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Bilateral Nivolumab-associated Vogt-Koyanagi-Harada-like Uveitis in a Patient with Metastatic Renal Cell Carcinoma].
    Czichos C; Wawrzynów B; Chamalis C; von Jagow B
    Klin Monbl Augenheilkd; 2021 Jun; 238(6):711-714. PubMed ID: 33395707
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.